Effective tracing of osteoporosis at a fracture and osteoporosis clinic in Groningen; an analysis of the first 100 patients;Doeltreffende opsporing van osteoporose in de fractuur- en osteoporosepolikliniek in Groningen; analyse na de eerste 100 patiënten

Nederlands Tijdschrift voor Geneeskunde

Volumn 148, Issue 44, 2004, Pages 2180-2185

  Hegeman, J H ^a   Willemsen, G ^a   Van Nieuwpoort, J ^a   Kreeftenberg, H G ^a   Van Der Veer, E ^a   Slaets, J P J ^a   Ten Duis, H J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIFEDIOL;

ADULT; AGED; ARTICLE; BONE DENSITY; CASE FINDING; DIAGNOSTIC VALUE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FRACTURE; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; OSTEOPENIA; OSTEOPOROSIS; OUTPATIENT; POPULATION RISK; PRACTICE GUIDELINE; SCORING SYSTEM;

25-HYDROXYVITAMIN D 2; BONE DENSITY; DENSITOMETRY, X-RAY; FRACTURES, BONE; HUMANS; MIDDLE AGED; NETHERLANDS; OSTEOPOROSIS; PREVALENCE; RISK FACTORS;

EID: 7544245219     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Laet CEDH de, Hout BA van, Pols HA. Osteoporosis in the Netherlands; a burden of illness study. Rotterdam: Institute for Medical Technology Assessment; 1996.
2. Osteoporose. Tweede herziene richtlijn. Alphen aan den Rijn: Van Zuiden Communications; 2002.
3. Burger H, Daele PLA van, Grashuis K, Hofman A, Grobbee DE, Schutte HE, et al. Vertebral deformities and functional impairment in men and women. J Bone Miner Res 1997;12:152-7.
4. Melton 3rd LJ, Crowson CS, O'Fallon WM. Fracture incidence in Olmsted County, Minnesota: comparison of urban with rural rates and changes in urban rates over time. Osteoporos Int 1999;9:29-37.
5. McLellan AR, Gallacher SJ, Fraser M, McQuillian C. The fracture liaison service: success of a program for the evaluation and management of patients with osteoporotic fracture. Osteoporos Int 2003;14:1028-34.
6. Ensrud KE, Black DM, Palermo L, Bauer DC, Barrett-Connor E, Quandt SA, et al. Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture intervention trial. Arch Intern Med 1997;157:2617-24.
7. Liberman UA, Weiss SR, Broll J, Minne HW, Quan H, Bell NH, et al. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med 1995;333:1437-43.
8. Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 1996;348:1535-41.
9. Cummings SR, Black DM, Thompson DE, Applegate WB, Barrett-Connor E, Musliner TA, et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture intervention trial. JAMA 1998:280:2077-82.
10. McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C, et al. Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group, N Engl J Med 2001;344:333-40
11. Orwoll E, Ettinger M, Weiss S, Miller P, Kendler D, Graham J, et al. Alendronate for the treatment of osteoporosis in men. N Engl J Med 2000;343:604-10.
12. Ho YV, Frauman AG, Thomson W, Seeman E. Effects of alendronate on bone density in men with primary and secondary osteoporosis. Osteoporos Int 2000;11:98-101.
13. Schuit SCE, Klift M van der, Weel AEAM, Laet CEDH de, Burger H, Seeman E, et al. Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam study. Bone 2004;34:195-202.
14. World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 1994;843:1-129.
15. Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int 1994;4:368-81.
16. Genant HK, Wu CY, Kuijk C van, Nevitt MC. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 1993;8:1137-48.
17. Eastell R, Barton I, Hannon RA, Chines A, Garnero P, Delmas PD. Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate. J Bone Miner Res 2003;18:1051-6.
18. Sambrook PN, Geusens P, Ribot C, Solimano JA, Ferrier-Barriendos J, Gaines K, et al. Alendronate produces greater effects than raloxifene on bone density and bone turnover in postmenopausal women with low bone density: results of EFFECT (Efficacy of FOSAMAX versus EVISTA comparison trial) international. J Intern Med 2004;255:503-11.
19. Freedman KB, Kaplan FS, Bilker WB, Strom BL, Lowe RA. Treatment of osteoporosis: are physicians missing an opportunity? J Bone Joint Surg Am 2000;82-A:1063-70.
20. Panneman MJM, Lips P, Sen SS, Herings RMC. Undertreatment with anti-osteoporotic drugs after hospitalization for fracture. Osteoporos Int 2004;15:120-4.
21. Cummings SR, Black DM, Nevitt MC, Browner W, Cauley J, Ensrud K. et al. Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet 1993;341:72-5.
22. Seeman E, Eisman JA. Treatment of osteoporosis: why, whom, when and how to treat. The single most important consideration is the individual's absolute risk of fracture. Med J Aust 2004;180:298-303.
23. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 1996;312:1254-9.
24. Silverman SL, Minshall ME, Shen W, Harper KD, Xie S. The relationship of health-related quality of life to prevalent and incident vertebral fractures in postmenopausal women with osteoporosis: results from the Multiple outcomes of raloxifene evaluation study. Health-Related Quality of Life Subgroup of the Multiple outcomes of raloxifene evaluation study, Arthritis Rheum 2001;44:2611-9.
25. Nevitt MC, Ettinger B, Black DM, Stone K, Jamal SA, Ensrud K, et al. The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann Intern Med 1998;128:793-800.
26. Ismail AA, Cockerill W, Cooper C, Finn JD, Abendroth K, Parisi G, et al. Prevalent vertebral deformity predicts incident hip though not distal forearm fracture: results from the European prospective osteoporosis study. Osteoporos Int 2004;12:85-90.
27. Dhesi JK, Moniz C, Close JCT, Jackson SHD, Allain TJ. A rationale for vitamin D prescribing in a falls clinic population. Age Ageing 2002;31:267-71.
28. Fisher A, Davis M. Is there rationale for vitamin D prescribing in the elderly population? Age Ageing 2003;32:235-6.